Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bowmed Ibisqus is a UK-based pharmaceutical company that specializes in the supply of generic injectable medicines to the hospital sector. The company focuses on providing high-quality, cost-effective alternatives to branded pharmaceuticals, primarily serving the National Health Service (NHS) and private hospital groups. Their product portfolio covers a wide range of therapeutic areas, including anti-infectives, critical care, oncology, and pain management. By leveraging a robust supply chain and regulatory expertise, Bowmed Ibisqus ensures the consistent availability of essential medicines for acute care settings. The company is recognized for its commitment to reliability and its role in supporting hospital pharmacy procurement strategies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bowmed Ibisqus.